INSIDE THE NHS: Innovation Still Driving Purchasing Decisions
This article was originally published in Clinica
In the second instalment of Clinica’s series on capital equipment purchasing trends in the English National Health Service, Kamaljot Dhami and Victor Chua of Mansfield Advisors discusses shifts in NHS market share among imaging equipment manufacturers and the factors driving these changes
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.